455 related articles for article (PubMed ID: 10192659)
1. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
3. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels.
Cattaneo M; Chantarangkul V; Taioli E; Santos JH; Tagliabue L
Thromb Res; 1999 Jan; 93(1):1-8. PubMed ID: 10065893
[TBL] [Abstract][Full Text] [Related]
4. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
[TBL] [Abstract][Full Text] [Related]
5. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation.
Margaglione M; D'Andrea G; d'Addedda M; Giuliani N; Cappucci G; Iannaccone L; Vecchione G; Grandone E; Brancaccio V; Di Minno G
Thromb Haemost; 1998 May; 79(5):907-11. PubMed ID: 9609218
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease.
Couturaud F; Oger E; Abalain JH; Chenu E; Guias B; Floch HH; Mercier B; Mottier D; Leroyer C
Respiration; 2000; 67(6):657-61. PubMed ID: 11124649
[TBL] [Abstract][Full Text] [Related]
7. A boy with venous thrombosis, homozygous for factor V Leiden, prothrombin G20210A and MTHFR C667t mutations, but belonging to an asymptomatic family.
Soria JM; Quintana R; Vallvé C; Iruin G; Cortés C; Fontcuberta J
Haematologica; 2000 Nov; 85(11):1230-2. PubMed ID: 11064483
[No Abstract] [Full Text] [Related]
8. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
Toydemir PB; Elhan AH; Tükün A; Toydemir R; Gürler A; Tüzüner A; Bökesoy I
J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
[TBL] [Abstract][Full Text] [Related]
9. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis.
Keijzer MB; den Heijer M; Blom HJ; Bos GM; Willems HP; Gerrits WB; Rosendaal FR
Thromb Haemost; 2002 Nov; 88(5):723-8. PubMed ID: 12428084
[TBL] [Abstract][Full Text] [Related]
10. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
[TBL] [Abstract][Full Text] [Related]
11. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia increases the risk of venous thrombosis independent of the C677T mutation of the methylenetetrahydrofolate reductase gene in selected Brazilian patients.
Morelli VM; Lourenço DM; D'Almeida V; Franco RF; Miranda F; Zago MA; Noguti MA; Cruz E; Kerbauy J
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):271-5. PubMed ID: 11943942
[TBL] [Abstract][Full Text] [Related]
13. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
14. Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease.
Domagala TB; Adamek L; Nizankowska E; Sanak M; Szczeklik A
Blood Coagul Fibrinolysis; 2002 Jul; 13(5):423-31. PubMed ID: 12138370
[TBL] [Abstract][Full Text] [Related]
15. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
[TBL] [Abstract][Full Text] [Related]
16. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis.
Amitrano L; Brancaccio V; Guardascione MA; Margaglione M; Iannaccone L; D'Andrea G; Marmo R; Ames PR; Balzano A
Hepatology; 2000 Feb; 31(2):345-8. PubMed ID: 10655256
[TBL] [Abstract][Full Text] [Related]
17. The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.
Koch HG; Nabel P; Junker R; Auberger K; Schobess R; Homberger A; Linnebank M; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S113-6. PubMed ID: 10650848
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy.
Murphy RP; Donoghue C; Nallen RJ; D'Mello M; Regan C; Whitehead AS; Fitzgerald DJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):266-70. PubMed ID: 10634828
[TBL] [Abstract][Full Text] [Related]
19. Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis.
Kluijtmans LA; Boers GH; Verbruggen B; Trijbels FJ; Novakova IR; Blom HJ
Blood; 1998 Mar; 91(6):2015-8. PubMed ID: 9490685
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations observed in arterial and venous thromboembolism--relevance for therapy, risk prevention and prognosis.
Harrington DJ; Malefora A; Schmeleva V; Kapustin S; Papayan L; Blinov M; Harrington P; Mitchell M; Savidge GF
Clin Chem Lab Med; 2003 Apr; 41(4):496-500. PubMed ID: 12747593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]